Stoneridge Investment Partners’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$77K Hold
20,603
0.06% 114
2025
Q1
$57K Hold
20,603
0.05% 105
2024
Q4
$114K Buy
+20,603
New +$114K 0.04% 115